Enterocins NKR-5-3A, B, C, and D were purified from the culture supernatant of Enterococcus faecium NKR-5-3 and characterized. Among the four purified peptides, enterocin NKR-5-3A (5242.3 Da) was identical to brochocin A, produced by Brochothrix campestris ATCC 43754, in mature peptides, and its putative synergistic peptide, enterocin NKR-5-3Z, was found to be encoded in ent53Z downstream of ent53A, encoding enterocin NKR-5-3A. Enterocin NKR-5-3B (6316.4 Da) showed a broad antimicrobial spectrum, and enterocin NKR-5-3C (4512.8 Da) showed high activity against Listeria. Enterocin NKR-5-3D (2843.5 Da), showing high homology to an inducing peptide produced by Lactobacillus sakei 5, induced the production of the enterocins. The enterocins showed different antimicrobial spectra and intensities. E. faecium NKR-5-3 concomitantly produced enterocins NKR-5-3A, B, C, and D which probably belong to different classes of bacteriocins. Furthermore, NKR-5-3 production was induced by enterocin NKR-5-3D.
Bacteriocins are ribosomally synthesized, extracellularly released, antimicrobial peptides or protein complexes that have a bactericidal or bacteriostatic effect, usually on closely related species. 1) Bacteriocin production has been observed in numerous species of bacteria. In the food industry, bacteriocin-producing lactic acid bacteria (LAB) are of particular interest as biopreservative organisms, 2) since most LAB can be consumed safely and can be used in food preservation.
Klaenhammer 1) and Nes et al. 3) have classified LAB bacteriocins previously into three main groups. More recently, a new classification scheme for bacteriocins has been suggested. 4) Class I bacteriocins, the so-called lantibiotics, contain unusual post-translationally modified amino acids, such as lanthionine and dehydrated amino acid. 5) Class II bacteriocins, the nonlantibiotic bacteriocins, are further divided into four subgroups. Class IIa are pediocin-like bacteriocins with strong antilisterial effects and a conserved N-terminal YGNGVXC consensus motif in the mature peptide. [6] [7] [8] Class IIb consist of two peptides, both of which are required for full antimicrobial activity. 9, 10) Class IIc are cyclic bacteriocins such as enterocin AS-48 11) and lactocyclicin Q.
12) The other class II bacteriocins are classified into class IId, which includes one-peptide and non-pediocin linear bacteriocins such as lactococcin A, divergicin A, lacticin Q, and lacticin Z. [13] [14] [15] [16] Recent studies have revealed that some LAB strains, including enterococci and lactobacilli, produce more than one type of bacteriocin. 17, 18) For example, Enterococcus faecium L50 produces three bacteriocins, enterocins L50, P, and Q. 19) Lactobacillus sakei 5 also produces three bacteriocins, sakacins P, T, and X. 20) Enterococci and lactobacilli are present in various environments, including in the normal gut microflora of humans and animals. Moreover, multiple bacteriocins with different characteristics are expected to control various bacteria more effectively. Thus, multiple bacteriocin-producing enterococci and lactobacilli can be useful in controlling the gut microflora, including pathogenic microorganisms. In addition, because of their potential in controlling other bacteria effectively, they are thought to be useful as starter strains in fermented foods.
Bacteriocin gene expression in some strains is regulated by a three-component signal pathway consisting of a histidine protein kinase, a response regulator, and an inducing peptide. In these cases, an inducing peptide secreted by the bacteriocin-producing strain itself activates transcription of the genes necessary for y To whom correspondence should be addressed. bacteriocin production. 4, 21, 22) For instance, Vaughan et al. reported that when Lb. sakei 5 produced no sakacins (P, T, or X) under an unfavorable culture conditions, the addition of inducing peptide IP-TX restored the production of sakacins T and X. 20) Wilaipun et al. 23) reported that Enterococcus faecium NKR-5-3 was isolated from a Thai fermented fish, pla-ra, and that its culture supernatant had antimicrobial activities against various bacteria, including Enterococcus, Lactobacillus, Bacillus, and Listeria. In addition, enterocins NKR-5-3A and B were purified from the culture supernatant, but their structures have not been determined.
In this study, we further succeeded in the purification and characterization of novel bacteriocins produced by E. faecium NKR-5-3. Strain NKR-5-3 was found to produce not only enterocins NKR-5-3A and B, but also enterocins NKR-5-3C, D, and Z. These bacteriocins showed different antimicrobial spectra and intensities against indicator strains. In addition, the amino acid sequences of enterocin NKR-5-3A, D, and Z were analyzed. Enterocin NKR-5-3D was found to have induction activity for bacteriocin production.
Materials and Methods
Bacterial strains and culture conditions. E. faecium NKR-5-3 was stored at À80 C in M17 medium (Merck, Darmstadt, Germany) with 15% glycerol, and propagated in M17 medium at 30 C for 22 h before use. Indicator strains for the determination of antimicrobial spectra were propagated at an appropriate temperature (30 C or 37 C), recommended by the culture collections, for 18 h before use. LAB indicator strains were grown in MRS broth (Oxoid, Basingstoke, UK), while the other indicator strains were grown in Tryptic Soy Broth (Difco, Sparks, MD) supplemented with 0.6% yeast extract (Nacalai Tesque, Kyoto, Japan) (TSBYE). Escherichia coli JM109 was cultivated in LB medium (Difco) with 1.5% agar containing 25 mg/mL of isopropyl--D-thiogalactopyranoside and 50 mg/mL of ampicillin. 24) Bacteriocin activity assay. Bacteriocin activities in the culture supernatant and the purified samples were assayed by the spot-on-lawn method 25) unless stated otherwise. Briefly, 10 mL of 2-fold dilutions of a bacteriocin preparation were spotted onto a double layer comprised of 5 mL of TSBYE with 0.6% agar inoculated with 50 mL culture of the indicator strain (about 10 7 CFU/mL) as top layer and 10 mL of Tryptic Soy Agar (Difco) with 0.6% yeast extract as bottom layer. After overnight incubation, the bacterial lawns were checked for inhibition zones. At the purification steps, the activity titer, expressed in arbitrary activity units (AUs) per milliliter of bacteriocin preparation, was defined as the reciprocal of the highest dilution causing a clear zone of growth inhibition in the indicator lawn. The minimum inhibitory concentrations (MICs) of the bacteriocins against various indicator strains were determined by the spot-on-lawn method with the purified bacteriocin solutions. The MICs were defined as the minimum concentrations of the bacteriocins that yielded clear zones of growth inhibition in the indicator lawns. All tests were performed in 3 times.
Bacteriocin purification. Bacteriocins were purified by a 4 step procedure from a 1-liter culture grown to stationary phase in M17 medium at 30 C for 22 h. The cells were removed by centrifugation at 9;000 Â g for 10 min, and 20 g of activated Amberlite XAD-16 resin (Sigma-Aldrich, St. Louis, MO) was added to the supernatant. The resin matrix was slowly shaken for 3 h, and the resin matrix was washed with Milli Q water and then with 50% (v/v) ethanol. Bacteriocins were eluted with 70% (v/v) isopropanol containing 0.1% trifluoroacetic acid (TFA). The active eluted solution was subjected to rotary evaporation to remove the isopropanol. The solution was then diluted with an equal volume of Milli Q water and loaded on an SP Sepharose Fast Flow cation-exchange chromatography column (length, 100 mm; internal diameter, 10 mm; GE Healthcare, Uppsala, Sweden) equilibrated with 50 mM sodium phosphate buffer (pH 5.6, PB), and then the column was washed with PB. Solution 1, containing enterocins NKR-5-3A and D, was eluted with washing PB, and then solution 2, containing enterocins NKR-5-3B and C, was eluted with PB containing 1.0 M NaCl. Solution 1 with 1.0 M ammonium sulfate was loaded on an Octyl Sepharose CL-4B hydrophobic interaction chromatography column (length, 50 mm; internal diameter, 10 mm; GE Healthcare) equilibrated with PB containing 1.0 M ammonium sulfate. The column was washed with PB, and then the active fraction (fraction 1) was eluted with PB containing 70% (v/v) ethanol. Solution 2 was separately loaded on the Octyl Sepharose column, and the active fraction (fraction 2) was eluted as in the case of fraction 1.
Active fraction 1 and fraction 2 were further purified by running them separately to a 3-mL Resource RPC column (GE Healthcare) in an LC-2000Plus high-performance liquid chromatography (HPLC) system (Jasco, Tokyo). Active fractions were eluted with a gradient of Milli Q-acetonitrile containing 0.1% TFA at a flow rate of 1. C. The antimicrobial activity of the fractions obtained at each purification step was determined as described above using the indicator strain E. faecalis JCM 5803
T . The peptide concentration of each fraction was estimated on the basis of the absorbance at 595 nm by the Coomasie Brilliant Blue (CBB) method (Nakalai Tesque). Bovine serum albumin (SigmaAldrich) was used for standard substance of the CBB method. For MIC determination and characterization of the bacteriocins, purified bacteriocins were concentrated with a SpeedVac concentrator (Savant, Farmingdale, NY) and dissolved at appropriate concentrations in 0.1% (v/v) Tween 80 except where otherwise indicated.
Mass spectrometry and amino acid sequencing. The molecular masses of the bacteriocins were analyzed by electrospray ionization time-of-flight mass spectrometry (ESI-TOF MS) with a JMS-T100LC mass spectrometer (JEOL, Tokyo). The amino acid sequences were determined by Edman degradation with protein sequencer model PPSQ-21 (Shimadzu, Kyoto, Japan).
DNA sequencing analysis. To clone the genes, E. coli JM109 was used as host strain. Total DNA was extracted from E. faecium NKR-5-3 as previously described. 15) To clone the genes encoding bacteriocins, PCR and DNA sequencing were performed using the primers listed in Table 1 . To identify the gene (ent53A) encoding enterocin NKR-5-3A, we used primers BrcA-F and BrcI-R based on the brochocin-C gene cluster (accession no. AF075600). 26) These primers and the total DNA were employed to amplify part of ent53A with Taq DNA polymerase (Promega, Madison, WI), following the standard protocol. 24) Total DNA was digested with BamHI, EcoRI, HindIII, KpnI, SacI, or XbaI (Nippon Gene, Tokyo), and the digested DNA was ligated into pUC18 cloning vector (Toyobo, Osaka) treated with the corresponding restriction enzymes and then dephosphorylated. Each of the various ligation products was used as template for PCR. To amplify the upstream and then downstream regions of ent53A, ligation-anchored and nested PCR were performed using ent53A specific primers and vector specific primers (1 st Mup13-f, Mup13-f, s-M13-r, 1 st Mup13-r, Mup13-r, and s-M13-r), as described previously, with some modifications. 12, 20, 27) To identify the gene (ent53D) encoding enterocin NKR-5-3D, we used degenerate primers (Dd-F1, Dd-F2, and Dd-F3) designed on the obtained amino acid sequence and vector specific primers for ligation-anchored and nested PCR. To amplify the upstream region of ent53D, primer IP-TX-pro based on the promoter region of stxP encoding IP-TX in Lb. sakei 5 (accession no. AY206863) 20) and specific primer PD-R1 based on the obtained sequence of ent53D were designed. The fragments obtained were purified using a QIAquick PCR purification kit (Qiagen, Hilden, Germany) and sequenced. Each fragment containing ent53A or ent53D was amplified by PCR using newly designed specific primers (PA-F4 and PA-R4, or PD-F1 and PD-R1 respectively) based on the nucleotide sequences obtained as above with the total DNA of strain NKR-5-3 as template. The resulting products were purified and sequenced directly to confirm the sequences obtained. DNA sequencing was carried out by Fasmac (Kanagawa, Japan).
Bacteriocin induction assay. E. faecium NKR-5-3 was propagated in TSBYE at 30 C for 22 h before use. In the analysis of the bacteriocin induction assay, the TSBYE culture inoculated with 1% of pre-culture of strain NKR-5-3 was incubated at 30 C, and 0.23 mM purified enterocin NKR-5-3D was added to the culture after 4 h of inoculation. The bacteriocin activity in the culture supernatant after 24 h of incubation from the inoculation was assayed by the spot-onlawn method using indicator strains E. faecalis JCM 5803
T and Listeria innocua ATCC 33090
T . The TSBYE culture without purified enterocin NKR-5-3D and the M17 culture served as negative and positive controls respectively. 
Results
Purification of and molecular mass determination for enterocins NKR-5-3
Bacteriocins from E. faecium NKR-5-3 were purified in 4 steps, as shown in Table 2 . In cation-exchange chromatography, bacteriocin activity was recovered mainly in the washing buffer and the 1.0-M NaCl fractions. At the final step of reverse-phase HPLC (2nd HPLC), antimicrobial peptides were obtained single peaks, which were designated enterocins NKR-5-3A, B, C, and D (Fig. 1) . The molecular masses of the purified bacteriocins were determined to be 5242.3, 6316.4, 4512.8, and 2843.5 Da for enterocins NKR-5-3A, B, C, and D respectively by ESI-TOF MS (Fig. 2) .
Structural analysis of enterocins NKR-5-3
The purified active fractions were collected and subjected to amino acid sequencing. After Edman degradation, the sequences of 24-amino acid residue of enterocin NKR-5-3A and 27-amino acid residue of enterocin NKR-5-3D were obtained. The obtained amino acid sequence of enterocin NKR-5-3A was identical to the N-terminal sequence of brochocin A, a component of brochocin-C produced by B. campestris ATCC 43754. 26) On the other hand, the calculated molecular mass of the obtained amino acid sequence of enterocin NKR-5-3D corresponded exactly to observed molecular mass of purified enterocin NKR-5-3D. The amino acid sequence of enterocin NKR-5-3D showed 88.9% and 63.0% identity to two inducing peptides, IP-TX produced by Lb. sakei 5 20) and AvcP produced by E. avium XA83 28) respectively (Fig. 3) . The amino acid sequences of enterocins NKR-5-3B and C have not yet been obtained by Edman degradation, probably because of the small amounts and/or N-terminal blocks. Amino acid sequence analyses of these peptides are ongoing.
Segments of the genes for enterocins NKR-5-3A and D were amplified by PCR using degenerate primers designed on the basis of the amino acid sequences obtained as above. Specific primers for ligation-anchored and nested PCR based on DNA sequences generated after amplification were constructed to obtain the adjacent sequences. The entire coding sequences of pre-enterocin NKR-5-3A (ent53A) and pre-enterocin NKR-5-3D (ent53D) were identified with putative ribosome binding sites (Fig. 4) . Mature enterocin NKR-5-3A encoded in ent53A corresponded exactly to mature brochocin A. In addition, the leader peptide sequences of pre-enterocins NKR-5-3A and D contained double glycine-type processing sites, but their leader sequences were different from those of brochocin A and IP-TX respectively. A putative bacteriocin structural gene, named ent53Z, was located downstream of ent53A (Fig. 4) . Its gene had 79.8% identity to the brochocin B structural gene. Its putative mature product, enterocin NKR-5-3Z, has two replaced amino acid residues as compared to brochocin B.
26) Enterocin NKR-5-3Z was detected only as a tiny signal at the purification step by ESI-TOF MS, but no antimicrobial activity by it was observed (data not shown).
Antimicrobial activity of the four purified bacteriocins Purified enterocins NKR-5-3 were tested for antimicrobial activity against various indicator strains ( Table 3 ). The culture supernatant showed notable inhibitory activity against L. innocua and E. faecalis. Enterocin NKR-5-3A, identified as brochocin A, a component of class IIb bacteriocin, showed markedly low activity against the indicator strains tested. Enterocin NKR-5-3B was active against a variety of grampositive bacteria. It showed high activity against Bacillus spp. and Lactococcus lactis, whereas it showed relatively little activity against L. innocua. Enterocin NKR-5-3C showed high activity against L. innocua and E. faecalis even at nanomolar concentrations. On the other hand, enterocin NKR-5-3D had a narrow antimicrobial spectrum. No synergistic antimicrobial activity was observed in any combination among enterocins NKR-5-3A, B, C, and D.
Induction of bacteriocin production by enterocin NKR-5-3D
Structural analysis indicated that enterocin NKR-5-3D is an inducing peptide for bacteriocin production (Fig. 3) . Bacteriocin induction activity was evaluated using the antimicrobial activity of the culture supernatants in TSBYE with purified enterocin NKR-5-3D. Cultures of M17 and TSBYE without enterocin NKR-5-3D were used as positive and negative control respectively. No bacteriocin production was observed in TSBYE (Table 4) , whereas the growth of strain NKR-5-3 was similar in cultures of TSBYE and M17 (data not shown). Thus TSBYE appears to be unfavorable for bacteriocin production by strain NKR-5-3. In the induction assay, the addition of enterocin NKR-5-3D to the TSBYE culture increased bacteriocin activity to the same level as M17 (Table 4) . Moreover, its addition to the M17 culture further increased the bacteriocin activity (by about 4-fold). The concentration of enterocin NKR-5-3D used in the induction assay, 0.23 mM, was lower than the MICs of indicator strains employed, Mass to charge ratio (m / z) Relative intensity (%) which should not affect antimicrobial activity. Thus enterocin NKR-5-3D induced bacteriocin production in strain NKR-5-3 and caused the strain to resume bacteriocin production even under unfavorable conditions.
Discussion
In ecological environments, intraspecific competition for ecological niches is waged continuously by microbes. For instance, bacteriocin-producing strains invest energy in bacteriocin production and control the microbial community for competitive advantage. 29) A large number of bacteriocin-producing strains have been isolated from a wide variety of sources. Few strains are reported to produce more than one bacteriocin.
Here we report the purification and characterization of novel multiple bacteriocins, enterocins NKR-5-3, in E. faecium NKR-5-3. Enterococci are lactic acid bacteria of importance in food, public health, and medical microbiology. Many enterococcal strains are known to produce bacteriocins, collectively called enterocin, and are known to be active against food-borne pathogenic gram-positive bacteria. reported to produce multiple bacteriocins, such as E. faecium WHE81 25) and E. faecium KU-B5.
30)
Enterocins NKR-5-3A, B, C, and D, produced by E. faecium NKR-5-3, were purified from the culture supernatant and their structures were analyzed. Enterocin NKR-5-3A (5242.3 Da) was identified as brochocin A, and the structural gene, ent53A, was identified. The antimicrobial activity of purified enterocin NKR-5-3A was low. This result suggests that enterocin NKR-5-3A needs a paired peptide, such as brochocin B, for full antimicrobial activity. In fact, ent53Z, a gene homologous to the brochocin B structural gene, was identified downstream of ent53A, but we detected it only as tiny signal similar to the putative molecular weight (3197.3 Da) of enterocin NKR-5-3Z encoded in ent53Z, in mass spectrometry. Brochocin B was not purified from the wild-type strain, but identified by DNA sequencing analysis, 26) suggesting that entrocin NKR-5-3Z is also difficult to purify under the purification conditions described above.
Enterocin NKR-5-3B was purified from the culture supernatant, but its amino acid sequence analysis has not yet been completed. Enterocin NKR-5-3B has broad antimicrobial activity, and its molecular mass (6316.4 Da) does not resemble any known bacteriocin, which indicates that enterocin NKR-5-3B is a novel bacteriocin.
Enterocin NKR-5-3C (4512.8 Da) showed high activity against L. innocua. In general, class IIa bacteriocins are described as listericidal, small (<10 kDa), unmodified peptides that have a limited spectra in comparison to other bacteriocins. 8) The antimicrobial spectrum of enterocin NKR-5-3C was similar to those of class IIa bacteriocins. In addition, no reported enterocins or other class IIa bacteriocins have the same molecular mass as enterocin NKR-5-3C, suggesting that this is a novel bacteriocin.
Enterocin NKR-5-3D (2843.5 Da) showed high homology to an inducing peptide, IP-TX. It was estimated to be an inducing peptide in view of the similar size. In fact, the induction activity of bacteriocin production of this peptide has been confirmed. In general, inducing peptides induce the transcription of genes involved in bacteriocin biosynthesis through a three-component signal pathway. 31) Further genetic analysis is necessary to clarify which bacteriocins are induced by enterocin NKR-5-3D and to identify the genes related to the threecomponent signal pathway. Also, enterocin NKR-5-3D had a narrow antimicrobial spectrum. In contrast, IP-TX has been reported to have no antimicrobial activity, 20) and most inducing peptides have no antimicrobial activity, except for plantaricin A. 32) In conclusion, novel multiple bacteriocins were purified from E. faecium NKR-5-3. Enterocins NKR-5-3A, B, C, and D, which probably belong to different classes, were produced concomitantly by the same strain. They showed different antimicrobial spectra and intensities against the indicator strains. In addition, although this strain produces multiple bacteriocins, the bacteriocin production was induced by enterocin NKR-5-3D. To our knowledge, E. faecium NKR-5-3 is the first reported enterococcal strain that produces at least four bacteriocins, including an inducing peptide. Multiple bacteriocin-producing strains, including strain NKR-5-3, are supposed to be more advantageous in controlling undesirable bacteria effectively. Since they can inhibit the growth of other bacteria using various weapons, they might be more useful in foods and related industries. The biosynthesis and induction mechanism of the bacteriocins in strain NKR-5-3 are to be further clarified.
